Lyell Immunopharma (LYEL) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.24
-0.22
-0.19
-0.17

Details

Expected EPS
-0.195
Actual EPS
-0.17
Surprise EPS
0.02
Surprise Percent
+12.82%

Description

Lyell Immunopharma (LYEL) has reported earnings of -0.17 per share for Q4 2024.

0 Comments

Share your thoughts